Skip to main content
. 2020 Mar 15;12(3):323–331. doi: 10.4251/wjgo.v12.i3.323

Table 1.

Clinicopathological features and survival of 61 malignant bowel obstruction cases

Clinicopathological features n (%) 6-mo OS Median survival time (mo) P value
Gender 0.923
Male 38 (65.2) 54.7% 6.6
Female 23 (34.8) 59.2% 6.4
Age (yr) 0.516
≥ 60 33 (54.1) 50.4% 6.5
< 60 28 (45.9) 61.5% 10.6
Primary tumor 0.015
Colorectal 51 (69.6) 83.6% 10.6
Gastric 10 (30.4) 16.4% 1.8
Differentiation 0.005
Well + Moderate 41 (67.2) 71.5% 10.9
Poor 20 (32.8) 26.5% 4.1
ECOG 0.031
0-1 40 (65.6) 64.4% 10.6
> 1 21 (34.4) 42.9% 5.1
Surgical approach 0.053
OBS 31 (50.8) 44.6% 5.3
MDS 30 (49.2) 68.6% 10.9
Obstruction 0.25
Single 41 (67.2) 57% 6.6
Multiple 20 (32.8) 55% 6.1
Intestinal obstruction 0.084
Yes 31 (50.8) 53.2% 6.1
No 30 (49.2) 60.1% 10.9
Colon/rectum obstruction 0.389
Yes 37 (60.7) 57.4% 10.9
No 24 (39.3) 54.8% 6.5
Ascites 0.691
Yes 15 (24.6) 41.1% 5.1
No 46 (75.4) 61.1% 6.6
Greater omentum metastasis 0.044
Yes 42 (68.9) 51.2% 6.1
No 19 (31.1) 67.5% 17.3
Distant metastasis 0.13
Yes 24 (39.3) 50% 5.2
No 37 (60.7) 60.4% 10.9
Symptom relief 0.007
Yes 46 (75.4) 63.7% 10.9
No 15 (24.6) 31.5% 3.9

OBS: Ostomy/by-pass surgery; MDS: Massive debulking surgery; ECOG: Eastern Cooperative Oncology Group; OS: Overall survival.